Lantheus Holdings (LNTH) Assets (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Assets came in at $2.3 billion in Q1 2026, up 14.18% year-on-year from $2.1 billion in Q1 2025, and up 5.35% on a QoQ basis from $2.2 billion in Q4 2025.
Lantheus Holdings (LNTH) Assets (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Assets data on file, last reported at $2.3 billion in Q1 2026.
- On a quarterly basis, Assets rose 14.18% year-over-year to $2.3 billion in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 14.18% increase from a year earlier, with the FY2025 full-year figure at $2.2 billion, up 12.48% from the prior year.
- Assets for Q1 2026 stood at $2.3 billion, up from $2.2 billion in the prior quarter.
- Over the last five years, Assets for LNTH reached as high as $2.3 billion in Q1 2026 and fell as low as $933.2 million in Q1 2022.
- Historically, Assets has averaged $1.7 billion across 5 years, with a median of $1.8 billion in 2024.
- Across the five-year window, Assets jumped 52.96% in 2022 and climbed 9.09% in 2025, its largest moves.
- Year by year, Assets stood at $1.3 billion in 2022, then gained by 24.97% to $1.7 billion in 2023, then rose by 19.94% to $2.0 billion in 2024, then gained by 12.48% to $2.2 billion in 2025, then gained by 5.35% to $2.3 billion in 2026.
- Per Business Quant data, the three most recent Assets figures were $2.3 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 2.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.35 Bn |
| Dec 31, 2025 | 2.23 Bn |
| Sep 30, 2025 | 2.28 Bn |
| Jun 30, 2025 | 2.12 Bn |
| Mar 31, 2025 | 2.06 Bn |
| Dec 31, 2024 | 1.98 Bn |
| Sep 30, 2024 | 2.05 Bn |
| Jun 30, 2024 | 1.94 Bn |
| Mar 31, 2024 | 1.83 Bn |
| Dec 31, 2023 | 1.65 Bn |
| Sep 30, 2023 | 1.52 Bn |
| Jun 30, 2023 | 1.34 Bn |
| Mar 31, 2023 | 1.35 Bn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.01 Bn |
| Mar 31, 2022 | 933.17 Mn |
| Dec 31, 2021 | 863.78 Mn |
| Sep 30, 2021 | 847.82 Mn |
| Jun 30, 2021 | 857.80 Mn |